Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum.

× No keyword cloud information.

26 in total

1. The pyretogenic effect of 5-hydroxytryptophan and its comparison with that of ISD.

Authors: A HORITA; J H GOGERTY
Journal: J Pharmacol Exp Ther Date: 1958-02 Impact factor: 4.030

2. Monoamine changes in the brain of rats injected with L-5-hydroxytryptophan.

Authors: F Okada; Y Saito; T Fujieda; I Yamashita
Journal: Nature Date: 1972-08-11 Impact factor: 49.962

3. Effect of 5-hydroxytryptophan on brain levels of dopamine, norepinephrine, and serotonin in mice.

Authors: G M Everett
Journal: Adv Biochem Psychopharmacol Date: 1974

Review 4. Biogenic amines and the states of sleep.

Authors: M Jouvet
Journal: Science Date: 1969-01-03 Impact factor: 47.728

5. Possible role of brain serotonin and dopamine in controlling male sexual behavior.

Authors: G L Gessa; A Tagliamonte
Journal: Adv Biochem Psychopharmacol Date: 1974

6. Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid.

Authors: N E Andén; T Magnusson; G Stock
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1973 Impact factor: 3.000

7. Release of ( 3 H)dopamine by L-5-hydroxytryptophan.

Authors: L K Ng; T N Chase; R W Colburn; I J Kopin
Journal: Brain Res Date: 1972-10-27 Impact factor: 3.252

8. A simple and sensitive fluorescence assay for monoamine oxidase and diamine oxidase.

Authors: S H Snyder; E D Hendley
Journal: J Pharmacol Exp Ther Date: 1968-10 Impact factor: 4.030

9. Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines.

Authors: W Lichtensteiger; U Mutzner; H Langemann
Journal: J Neurochem Date: 1967-05 Impact factor: 5.372

10. An evaluation of the use of intraventricularly administered [3H]5-hydroxytryptamine as a marker for endogenous brain 5-hydroxytryptamine.

Authors: D W Gallager; E Sanders-Bush; G K Aghajanian; F Sulser
Journal: Brain Res Date: 1975-07-25 Impact factor: 3.252

9 in total

1. Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.

Authors: J Tiihonen; M Kuoppamäki; K Någren; J Bergman; E Eronen; E Syvälahti; J Hietala
Journal: Psychopharmacology (Berl) Date: 1996-08 Impact factor: 4.530

2. Evidence against serotonin involvement in the tonic component of electrically induced convulsions and in carbamazepine anticonvulsant activity.

Authors: V Crunelli; S Bernasconi; R Samanin
Journal: Psychopharmacology (Berl) Date: 1979 Impact factor: 4.530

Review 3. Presynaptic control of serotonin on striatal dopamine function.

Authors: Sylvia Navailles; Philippe De Deurwaerdère
Journal: Psychopharmacology (Berl) Date: 2010-10-16 Impact factor: 4.530

4. Development of tolerance to the wet-dog shake behaviour but not the increase in seizure threshold induced by L-5-hydroxytryptophan during continued treatment in rats.

Authors: S R Pagliusi; W Löscher
Journal: Psychopharmacology (Berl) Date: 1985 Impact factor: 4.530

5. The effect of long-term concurrent administration of chlorpromazine and lithium on the striatal and frontal cortical dopamine metabolism in rats.

Authors: L Eroğlu; A Hizal; H Koyuncuoğlu
Journal: Psychopharmacology (Berl) Date: 1981 Impact factor: 4.530

On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum.